At the 2025 Erdhem-Chester Disease Medical Symposium in Barcelona, the ECDGA Junior Investigator Award went to Laura Eurelings of Erasmus University Medical Centre, Rotterdam.
Her poster, “Anti-IL-6 Therapy in Rare Histiocytic Disorders: Erdheim-Chester and Rosai-Dorfman Disease,” showed that tocilizumab may potentially be an effective option for patients, especially those who are mutation-negative or not eligible for BRAF inhibitors.
Research involvement by early career investigators brings fresh ideas and new energy—helping move rare disease science forward. Laura’s work is a perfect example of how junior investigators are making real impacts, improving ECD knowledge!
Join us in celebrating Laura’s achievement and her contribution to the ECD community.